Bryan Garnier - Roche Holding AG ADS (RHHBY) ROCHE: Tecentriq gets accelerated approval for PD-L1+ TNBC in the US | BUY - Top Picks | CHF315

Report

Bryan Garnier

Eric Le Berrigaud

ROCHE: Tecentriq gets accelerated approval for PD-L1+ TNBC in the US | BUY - Top Picks | CHF315

ROCHE - BUY - Top Picks | CHF315(+16%)
Tecentriq gets accelerated approval for PD-L1+ TNBC in the US

FDA grants accelerated approval to Tecentriq in TNBC
More to be achieved in TNBC
A sizeable opportunity for Tecentriq

11/03/2019 3 EN

Underlying

Roche Holding AG ADS

See profile

US7711951043 Pink OTC Markets Switzerland

Provider

Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

See profile

Analysts

Eric Le Berrigaud

Other Reports on these Companies

Independent Investment Research

Monthly LMI Update Independent Investment Research

Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked. This compares to the total dividends of 5 cents per share in FY20. The Board has confirmed that, in...

August 6, 2021 August 6, 2021 10 EN

Vermilion Research

Vermilion Compass: Weekly Equity Strategy

ields Testing Support Ahead Of FOMC Meeting We continue to see signs of improving risk appetites alongside healthy market dynamics. As a result, our outlook remains constructive. A breakout to new highs in the Russell 2000 (IWM) and Russell Micro-Caps (IWC), above $234.50 and $159, would likely cause us to shift to an outright bullish stance. Small- & Micro-Caps. The Russell 2000 (IWM) and Russell Micro-Caps (IWC) are testing key resistance at $234.50 and $159, respectively. Sustained breakouts above these levels would be a very healthy sign for the broad market and we would shift to an outr...

EUR 46.71

June 15, 2021 June 15, 2021 1 EN

Vermilion Research

Vermilion Int'l Compass: Global Equity Strategy

Lower High Forming? Major global indexes are showing waning upside momentum and we believe near-term consolidation is likely. This is supported by the charts and the idea that consolidation makes sense following the massive gains off of the March lows. We also believe that the market is in a â€œwait-and-seeâ€ phase as it relates to states and countries re-opening. A resolution of this consolidation period above resistance (bullish) or below support (bearish) will tell us where the major global averages are headed next. Â· Wedge/Uptrend Breakdowns. Last week we highlighted potential ...

EUR 46.71

May 7, 2020 May 7, 2020 21 EN

NHOA: Slow start into 2024

NHOA reported Q1 revenue of EUR58m (+57% YoY, -26% QoQ), a rather low quarter compared to FY24 revenue expectations (cons. at EUR430m), but with NHOA exposed to the overall pace of project deliveries in Energy Storage that can vary significantly quarter on quarter. Revenue mix did not improve this

15h / 1m 15h / 1m 1 EN

Maria Vara

Maria Vara

XVIVO: delivering a solid Q1 2024 performance

XVIVO reported Q1 2024 results with a YoY organic growth of 32% (32% adj. for currency) in net sales raising to SEK 186m. The solid performance was driven by i) thoracic business reporting a 33% YoY growth, totalling SEK 121m sales, with disposables sales rising by 39% as of larger utilization in t

15h / 7m 15h / 7m 1 EN

Cedric Rossi

Cedric Rossi

BIC: Soft Q1 followed by a gradual acceleration from Q2 onwards

Yesterday, BIC unveiled Q1 numbers that reflected management's message highlighting a soft start to the year, but showed a modest miss vs CSS expectations (sales: -1% / aEBIT: -1.5%) given the negative phasing impact in Lighters (38% of sales and 69% of aEBIT before unallocated costs). With trends

15h / 25m 15h / 25m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN